首页> 中文期刊> 《中国医科大学学报》 >非何杰金恶性淋巴瘤病人血清及瘤组织中β-葡萄糖醛酸酶同步测定及意义

非何杰金恶性淋巴瘤病人血清及瘤组织中β-葡萄糖醛酸酶同步测定及意义

         

摘要

目的:探索非何杰金恶性淋巴瘤病人体内β-葡萄糖醛酸酶(β-glucuronidase,β-G)的变化规律。方法:采用酶联免疫吸附测定(enzyme-linked immunsorbent assay,ELISA)方法,免疫组织化学方法对13例非何杰金恶性淋巴瘤患者血清及瘤组织中β-G进行同步测定,并对其中3例进行了免疫电镜研究。结果:β-G在非何杰金恶性淋巴瘤患者血清及瘤组织中均呈明显表达,与对照组有显著性差异(P<0.01)。结论:对β-G进行机能学与形态学的联合检测,可能成为非何杰金恶性淋巴瘤诊断的辅助指标。%Objective: Our purpose was to explore the change regularity of β-glucuronidase (β-G) in body of patients with Non-Hodgkin malignant lymphoma. Methods: β-G was examined synchronously both in the serum and in the tumor tissue of 13 cases patient with Non-Hodgkin malignant lymphoma by using the method of enzymlinked immunsorbent assay (ELISA) and immunohistochemistry separately. Among them, 3 cases were studied by using the immuno electron microscopic technique. Results: β-G was highly expressed both in the serum and tumorous tissue in patients with non-Hodgkin malignant lymphoma and there was obviously difference as compared with the control group (P<0.01). Conclusion: The combined detection with functional and morphological methods to β-G, it may be assistant target to early discovery and early diagnosis of Non-Hodskin malignant lymphoma.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号